NewsRx

Search our medical news database

Angeion Corporation

Angeion Corporation Reports Second Quarter Results

Published in Physician Law Weekly, June 18th, 2008

Angeion Corporation (NASDAQ: ANGN) reported results for its fiscal 2008 second quarter ended April 30, 2008.

For the 2008 second quarter, Angeion announced a net loss of $373,000, or $0.09 per diluted share, on revenues of $7.3 million. This compares to 2007 second quarter net income of $453,000, or $0.11 per diluted share, on revenues of $10.0 million. Angeion's 2008 second quarter revenues were adversely affected by $1.9 million compared to the 2007 second quarter due to the conclusion of a customer's nonrecurring clinical trial program.

The Company reported that its gross margin rose to 52.4 percent in the fiscal 2008 second quarter, up from 50.5...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook